Objective: This study was designed to assess sexual dysfunction in women suffering from type 2 diabetes mellitus. Subjects and Methods: Forty-five type 2 diabetic, non-menopausal married women, aged 20-55 years, who were referred to Shahid Labbafinejad Clinics from March 2008 to June 2009 were included in this study. They were compared to 91 non-diabetic volunteers. Sexual function was evaluated by the sexual function questionnaire. Genitourinary examination was performed in all subjects. Blood sample tests were requested for fasting blood sugar, hemoglobin A1c, 2-hour postprandial glucose and lipid profile measurements. Ophthalmologic and neurologic examinations (checking deep tendon reflexes) were done for cases. Results: The mean age of cases and controls was 42.17± 5.91 and 34.96 ± 8.30 years, respectively (p < 0.001). The prevalence of a high probability of female sexual dysfunction in 6 domains including desire, arousal sensation, arousal lubrication, orgasm, pain and enjoyment was 71.1, 84.4, 55.6, 71.1, 8.9 and 66.7% in the diabetes mellitus women and 56.6, 67.0, 59.3, 57.1, 25.3 and 53.8% in the non-diabetic volunteers, respectively. Differences were statistically significant in the 3 domains of desire, arousal sensation and pain (p < 0.05). Deep tendon reflexes were normal in all and 12.5% showed diabetic retinopathy. Conclusions: Sexual dysfunction in cases as well as in controls was high; however, further studies with a higher number of patients are needed to confirm the results.

Keywords:
Female sexual dysfunction, Diabetes mellitus
1.
World Health Organization: Defining sexual health: report of a technical consultation on sexual health. Geneva, WHO, 2002.
2.
Ellenberg M: Impotence in diabetes: the neurologic factor. Ann Intern Med 1971;75:213-219.
3.
Rubin A, Babbott D: Impotence and diabetes mellitus. J Am Med Assoc 1958;168:498-500.
4.
Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ: Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996;19:135-141.
5.
Rosen RC, Taylor JF, Leiblum SR, Bachmann GA: Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993;19:171-188.
6.
Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
7.
Goldmeier D, Judd A, Schroeder K: Prevalence of sexual dysfunction in new heterosexual attenders at a central London genitourinary medicine clinic in 1998. Sex Transm Infect 2000;76:208-209.
8.
Bhasin S, Enzlin P, Coviello A, Basson R: Sexual dysfunction in men and women with endocrine disorders. Lancet 2007;369:597-611.
9.
Shifren JL, Davis SR, Moreau M, et al: Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study. Menopause 2006;13:770-779.
10.
Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR: The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-17.
11.
Salonia A, Munarriz RM, Naspro R, et al: Women's sexual dysfunction: a pathophysiological review. BJU Int 2004;93:1156-1164.
12.
Giraldi A, Kristensen E: Sexual dysfunction in women with diabetes mellitus. J Sex Res 2010;47:199-211.
13.
Education and treatment in human sexuality: the training of health professionals. Report of a WHO meeting. World Health Organ Tech Rep Ser 1975;572:5-33.
14.
Meeking DR, Fosbury JA, Cummings MH, et al: Sexual dysfunction and sexual health concerns in women with diabetes. Sex Dysfunct 1999;I:83-87.
15.
Fatemi SS, Taghavi SM: Evaluation of sexual function in women with type 2 diabetes mellitus. Diab Vasc Dis Res 2009;6:38-39.
16.
Schreiner-Engel P, Schiavi RC, Vietorisz D, De Simone Eichel J, Smith H: Diabetes and female sexuality: a comparative study of women in relationships. J Sex Marital Ther 1985;11:165-175.
17.
Safarinejad MR: Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res 2006;18:382-395.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.